# A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test

> **NCT01936025** · PHASE2 · COMPLETED · sponsor: **Profil Institut für Stoffwechselforschung GmbH** · enrollment: 34 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Dextromethorphan
- **DRUG:** Sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01936025
- **Lead sponsor:** Profil Institut für Stoffwechselforschung GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936025, "A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01936025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*